Back to search
FDAFDA · Food and drugs·Recall number Z-1287-2013

NeuraGen Nerve Guide NeuraGen Nerve Guide is indicated for repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity.

Published May 22, 2013 · Recall initiated: March 28, 2013

Summary

FDA records medical device Class II recall Z-1287-2013, published May 22, 2013 and initiated March 28, 2013. Recalling firm: Integra LifeSciences Corporation; Status: Terminated; Reported quantity: 1,661 boxes; Lot: 1105457 1112377, 1112378 1112103 1112106, 1112003, 1112296, 1110715 1112052, 1112004, 1112030 1111972 1112376. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Integra LifeSciences Corporation
Distributor
Worldwide distribution: USA (nationwide) including Puerto Rico and countries of: Arab Emirates, Argentina, Belgium, Brasil, Canada, Chile, China, Costa Rica, Denmark, Egypt, Spain, France, Great Britain, Italy, Japan, Peru, Singapore, Thailand, and South Africa.
Lot
1105457 1112377, 1112378 1112103 1112106, 1112003, 1112296, 1110715 1112052, 1112004, 1112030 1111972 1112376
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was NeuraGen Nerve Guide NeuraGen Nerve Guide is indicated for repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity. recalled?

Yes. FDA published recall Z-1287-2013 on May 22, 2013. Reported hazard: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.

What should I do if I have this product?

Voluntary: Firm initiated · Letter